Your browser doesn't support javascript.
loading
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon.
Lew, Thomas E; Bennett, Rory; Lin, Victor S; Whitechurch, Ashley; Handunnetti, Sasanka M; Marlton, Paula; Shen, Yandong; Mulligan, Stephen P; Casan, Joshua; Blombery, Piers; Tam, Constantine S; Roberts, Andrew W; Seymour, John F; Thompson, Philip A; Anderson, Mary A.
Afiliación
  • Lew TE; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Bennett R; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Lin VS; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
  • Whitechurch A; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Handunnetti SM; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Marlton P; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Shen Y; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
  • Mulligan SP; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Casan J; Department of Hematology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Blombery P; Department of Hematology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Tam CS; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
  • Roberts AW; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Seymour JF; Kolling Institute, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Thompson PA; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Anderson MA; Kolling Institute, Royal North Shore Hospital, Sydney, NSW, Australia.
Blood Adv ; 8(6): 1439-1443, 2024 Mar 26.
Article en En | MEDLINE | ID: mdl-38231032
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia Linfocítica Crónica de Células B Límite: Humans Idioma: En Revista: Blood Adv Año: 2024 Tipo del documento: Article País de afiliación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia Linfocítica Crónica de Células B Límite: Humans Idioma: En Revista: Blood Adv Año: 2024 Tipo del documento: Article País de afiliación: Australia